Clinical Cancer Research Targets Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 5810, October 1, 2007. doi: 10.1158/1078-0432.CCR-07-0343
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Heer, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Heer, P.

Imaging, Diagnosis, Prognosis

Caspase-3 Activity Predicts Local Recurrence in Rectal Cancer

Pieter de Heer1, Elza C. de Bruin2, Elma Klein-Kranenbarg1, Remco I.J.M. Aalbers1, Corrie A.M. Marijnen6, Hein Putter3, Hans J. de Bont5, J. Fred Nagelkerke5, J. Han J.M. van Krieken7, Hein W. Verspaget4, Cornelis J.H. van de Velde1, Peter J.K. Kuppen1 for the Dutch Colorectal Cancer Group

Authors' Affiliations: Departments of 1 Surgery, 2 Clinical Oncology, 3 Medical Statistics, and 4 Gastroenterology, Leiden University Medical Centre; 5 Department of Toxicology, Leiden Amsterdam Centre for Drug Research, Leiden, the Netherlands; 6 Department of Radiotherapy, the Netherlands Cancer Institute, Amsterdam, the Netherlands; and 7 Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands

Requests for reprints: Peter J.K. Kuppen and Cornelis J.H. van de Velde, Department of Surgery, Leiden University Medical Center, P. O. Box 9600, 2300 RC Leiden, the Netherlands. Phone: 31-71-5262309; Fax: 31-71-5266750; E-mail: P.J.K.Kuppen{at}lumc.nl and C.J.H.van_de_Velde{at}lumc.nl.

Purpose: Radiotherapy followed by total mesorectal excision surgery has been shown to significantly reduce local recurrence rates in rectal cancer patients. Radiotherapy, however, is associated with considerable morbidity. The present study evaluated the use of biochemical detection of enzymatic caspase-3 activity as preoperative marker for apoptosis to preselect patients that are unlikely to develop a local recurrence to spare these patients from overtreatment and the negative side effects of radiotherapy.

Experimental Design: Nonirradiated freshly frozen tissue samples from 117 stage III rectal cancer patients were collected from a randomized clinical trial that evaluated preoperative radiotherapy in total mesorectal excision surgery. Additional frozen archival tissues from 47 preoperative biopsies and corresponding resected colorectal tumors were collected. Level of apoptosis was determined by measuring the enzymatic activity of caspase-3 in a biochemical assay.

Results: In tumor tissue, caspase-3 activity lower than the median was predictive of 5-year local recurrence (hazard ratio, 7.4; 95% confidence interval, 1.7-32.8; P = 0.008), which was unaffected by adjustment for type of resection, tumor location, and T status (adjusted hazard ratio, 7.5; 95% confidence interval, 1.7-34.1; P = 0.009). Caspase-3 activity in preoperative biopsies was significantly correlated with caspase-3 activity in corresponding resected tumors (r = 0.56; P < 0.0001).

Conclusion: Detection of tumor apoptosis levels by measuring caspase-3 activity, for which a preoperative biopsy can be used, accurately predicted local recurrence in rectal cancer patients. These findings indicate that caspase-3 activity is an important denominator of local recurrence and should be evaluated prospectively to be added to the criteria to select rectal cancer patients in which radiotherapy is redundant.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
S. Thomasset, D. P. Berry, H. Cai, K. West, T. H. Marczylo, D. Marsden, K. Brown, A. Dennison, G. Garcea, A. Miller, et al.
Pilot Study of Oral Anthocyanins for Colorectal Cancer Chemoprevention
Cancer Prevention Research, July 1, 2009; 2(7): 625 - 633.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. J. E. M. Gosens, R. C. Dresen, H. J. T. Rutten, G. A. P. Nieuwenhuijzen, J. A. W. M. van der Laak, H. Martijn, I. Tan-Go, I. D. Nagtegaal, A. J. C. van den Brule, and J. H. J. M. van Krieken
Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours
Ann. Onc., December 1, 2008; 19(12): 2026 - 2032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.